The first small molecules capable of strongly suppressing proliferation of cancer cells harboring BRAF class I/II/III mutations.

Abstract excerpt

BRAF mutants are categorized into three classes according to dependency on RAS signaling and RAF dimerization-dependency. Class I BRAF V600 mutants (RAS-independent monomer) are sensitive to vemurafenib. In contrast, both class II mutants (RAS-independent dimer) and class III mutants (RAS-dependent heterodimer) are insensitive to vemurafenib. It is not likely that BRAF inhibitors capable of inhibiting all classes...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bridged Bicyclo Compounds, Heterocyclic
• Share to Drug Resistance, Neoplasm